A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma-Reference-Cited by-同舟云学术

A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma

Published:2017-09-14 Issue:25 Volume:24 Page:
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Mercurio Annalisa¹,Adriani Giulia²,Catalano Alessia¹,Carocci Alessia¹,Rao Luigia³,Lentini Giovanni¹,Cavalluzzi Maria M.¹,Franchini Carlo⁴,Vacca Angelo³,Corbo Filomena⁵

Affiliation:

1. Department of Pharmacy-Drug Sciences, University of Bari, A. Moro, Bari, Italy

2. BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology, Singapore

3. Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy

4. Department of Pharmacy-Drug Sciences, University of Bari A. Moro�, Bari, Italy

5. Department of Pharmacy- Drug Sciences, University of Bari, A. Moro�, Bari, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma;Expert Review of Hematology;2024-02-06

2. Emerging applications of anti-angiogenic nanomaterials in oncotherapy;Journal of Controlled Release;2023-12

3. Molecular targets and therapeutic strategies for triple-negative breast cancer;Molecular Biology Reports;2023-11-04

4. Cancer drugs with high repositioning potential for Alzheimer’s disease;Expert Opinion on Emerging Drugs;2023-10-02

5. Clinical efficacy of Thalidomide combined with PAD Regimen in patients with multiple Myeloma;Pakistan Journal of Medical Sciences;2023-07-10